Effects of Qili Qiangxin Capsule on AQP2, V2R, and AT1R in Rats with Chronic Heart Failure
QL reduces the levels of plasma AVP and renal V2R protein expression in CHF rats. (a) AVP levels in plasma were elevated in CHF rats; treatment with QL decreased AVP levels in plasma; however treatment with Valsartan had no effect on plasma AVP in CHF rats. (b) Renal V2R protein increased in CHF rats; treatment with QL significantly attenuated renal V2R protein in CHF rats. (, versus the CHF group, , versus the sham group).